Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 16.9.2026Baxter Holding B.V. (BAX-NL-1)53712Caelyx pegylated liposomal 2 mg/ml infúzny koncentrát (con inf 1x10 ml (liek.inj.skl.))11.9.2026R
 15.9.2026Baxter Slovakia s.r.o. (BAX-SK)0385BEndoxan 500 mg prášok na injekčný roztok (plv ino 6x500 mg (liek.inj.skl.))14.9.2026R
 15.9.2026G.L. Pharma GmbH (GLH-2)0666EPazopanib G.L. Pharma 400 mg filmom obalené tablety (tbl flm 30x400 mg (blis.Al/PVC/PE/PVDC))16.9.2026O
 15.9.2026G.L. Pharma GmbH (GLH-2)89806Oxypro 80 mg tablety s predĺženým uvoľňovaním (tbl plg 60x80 mg (blis.PVC/PVDC/Al))15.9.2026R
 14.9.2026Novartis Europharm Limited (NEH-IE)4579ESimulect 20 mg prášok na injekčný alebo infúzny roztok (plo jof 1x20 mg (liek.inj.skl.))14.9.2026R
 14.9.2026B.Braun Melsungen AG (BME)9311CViant (plv ifo 10x932 mg (liek.inj.skl.jantárová))14.9.2026R
 14.9.2026B.Braun Melsungen AG (BME)34254Glukóza B. Braun 5 % infúzny roztok (sol inf 10x500 ml (fľ.LDPE))14.9.2026O
 11.9.2026ratiopharm GmbH (RAT)33472Lisinopril-ratiopharm 20 mg (tbl 30x20 mg (blis.PVC/Al))20.10.2026R
 11.9.2026Zentiva, k.s. (ZNT-1)2456EDaruph 79 mg (tbl flm 30x79 mg (blis.OPA/Al/PVC/Al))14.9.2026O
 11.9.2026Zentiva, k.s. (ZNT-1)2452EDaruph 55 mg (tbl flm 60x55 mg (blis.OPA/Al/PVC/Al))14.9.2026O
 11.9.2026Zentiva, k.s. (ZNT-1)3041BTorvacard Novum 10 mg (tbl flm 90x10 mg (blis.OPA/Al/PVC/Al))18.9.2026O
 11.9.2026Zentiva, k.s. (ZNT-1)2513DZetovar 10 mg/40 mg tablety (tbl 90x10 mg/40 mg (blis.OPA/Al/PVC))21.9.2026O
 11.9.2026Actavis Group PTC ehf. (ACT-10)31908Desloratadine Actavis 5 mg filmom obalené tablety (tbl flm 50x5 mg (blis.OPA/Al/PVC/Al))26.10.2026R
 11.9.2026TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)8598DPaliperidón Teva 150 mg injekčná suspenzia s predĺženým uvoľňovaním (sus ijp 1x150 mg (striek.inj.napln.+2x ihla))19.10.2026R
 11.9.2026KRKA, d.d., Novo mesto (KRK-2)6286AElicea Q-Tab 10 mg orodispergovateľné tablety (tbl oro 28x10 mg (blis.OPA/Al/PVC s odlup.fóliou PET/Al))14.9.2026R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)